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Background: Buyang Huanwu Decoction (BYHWD), a traditional Chinese medicine formula, has been shown to exert
a variety of pharmacological effects including neuroprotective properties. However, the mechanism of neuroprotection
is not fully understood. This study was designed to explore the mechanism of BYHWD in the treatment of spinal
ischemia-reperfusion injury in rats.
Methods: Twenty-eight male Sprague–Dawley rats, weighting 250–280 g, were used, and were randomly divided into
four groups with 7 animals in each: sham operation group (Control), spinal ischemia with saline (SI + Saline), spinal
ischemia with BYHWD (SI + BYHWD), and spinal ischemia with roscovitine (SI + R). After 60 minutes of spinal ischemia
followed by 72 hours of reperfusion, motor function of hind limbs, spinal ischemic infarction volume, the number of
apoptotic cells, and cyclin-dependent kinase 5 (Cdk5) were examined.
Result: Ischemia-reperfusion resulted in injury of the spines, while BYHWD significantly improved spinal function. The
spinal infarction volume, number of apoptotic cells, and Cdk5 were decreased by administration of BYHWD. The similar
improvements were seen with the pre-treatment of roscovitine.
Conclusions: BYHWD prevented the ischemia-reperfusion-induced spinal injury in rats. The protective function of
BYHWD was, in part, linked with inhibition of Cdk5.
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Surgeries on the thoracic and abdominal aorta or trauma
may result in paraplegia or paraphrases, as complication
of spinal orthopedic procedure and thoracoabdominal
aneurymectomy [1] or association of trauma [2]. Although
different protective techniques have been recommended
in order to lower morbidity and neurologic sequelae, using
these experimental therapies as a clinical treatment is still
challenging [3].
Buyang Huanwu Decoction (BYHWD), a well-known
traditional Chinese medicine formula, has been used for
the treatment of paralysis and stroke for hundreds of years,
and has increasingly gained attention due to its significant* Correspondence: wlei_78@yahoo.com.cn
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distribution, and reproduction in any mediumneuroprotective properties. Clinical efficacy of BYHWD in
the neuroprotective effects has been reported recently [4].
The reported mechanisms of BYHWD on the treatment of
ischemic brain and spinal injuries have involved the thiore-
doxin system [5] and glutamate [6]. Those published find-
ings, however, cannot fully explain the neuroprotective
mechanisms of BYHWD on spinal ischemia-reperfusion
injury, and other different factors may be involved in the
protective mechanisms.
Cyclin-dependent kinase 5 (Cdk5) has been shown to be
crucial for neuronal migration in the spinal cord [7,8], and
to exert beneficial effects on the ischemia-reperfusion
injury in the neuronal system [9]. The expression of Cdk5
is up-regulated during neuronal death in response to
different toxic stimuli [10,11]. Thus, reducing activationtral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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of spinal ischemia-reperfusion injury.
We have speculated that the therapeutic effect of
BYHWD on spinal ischemia-reperfusion injury may link
with the reduction of Cdk5. Therefore, the present study
was designed to explore if Cdk5 was involved in the
underlying therapeutic mechanism of BYHWD.
Methods
All animal care complied with the guidelines for labora-
tory animals, and the study was approved by the Ethics
Committee of Chongqing University.
Composition and preparation of BYHWD
BYHWD is composed of Radix Astragali (120 g), Radix
Angelicae Sinensis (6 g), Radix Paeoniae Rubra (6 g),
Rhizoma Chuanxiong (3 g), Semen Persicae (3 g), Flos
Carthami (3 g) and Lumbricus (3 g). All dried crude drugs
were provided by Jiangsu Pharmacy Company (Nanjing,
China), identified by the Department of Pharmacology,
Chongqing Medical University, and mixed in the ratio
of 120:6:6:3:13:3:3. The herbs were decocted by boiling
in distilled water for 30 minutes. The solution was then
freeze-dried under vacuum, and made into a powder.
The powder was dissolved in distilled water to a final
concentration of 5 g/ml (equivalent to dry weight of raw
materials).
Experimental Animals and Induction of Spinal Cord
Ischemia-reperfusion
Twenty-eight male Sprague–Dawley rats, weighting 250–
280 g, were used in the study. The animals were randomly
divided into four groups with 7 animals in each: sham
operation group (Control), spinal ischemia with saline
(SI + Saline), spinal ischemia with BYHWD (SI + BYHWD),
and spinal ischemia with roscovitine (SI + R).
Spinal cord ischemia-reperfusion was induced by using
the previously described method [5]. All animals were
anesthetized with chloral hydrate (350 mg/kg) adminis-
tered intraperitoneally. The temperature was continuously
monitored with a rectal probe inserted 5 cm into the
rectum. The temperature was maintained at 37 ± 0.5°C
with an infrared heat lamp and a heating pad. The
femoral artery was cannulated with a polyethylene tube
(PE-50) to facilitate continuous monitoring of heart rate
and arterial blood pressure, and for collecting blood
samples for the analysis of blood gases and blood pH.
Laser-Doppler flowmetry was recorded continuously
during surgery using a method described previously [5].
Ischemia of the lumbar spinal cord was produced by oc-
clusion of the abdominal aorta 0.5 cm below the left
renal artery for 60 minutes, followed by 72 hours of re-
perfusion. Sham operation rats underwent the same
procedure, but no occlusion of the aorta was performed.Rats in the both SI + Saline and SI + BYHWD groups
were administered with 8 ml of saline and 40 g/kg of
BYHWD, respectively, by intragastric infusion, starting
at reperfusion, 30, 60, 120, 240 and 360 minutes after
reperfusion, and then the same dose was infused every
24 hours for 3 days. The dosage of BYHWD was chosen
as previously described [5].
To examine whether Cdk5 was involved in apoptosis
caused by spinal ischemia-reperfusion, the selective inhibi-
tor of Cdk5, roscovitine, was used in the SI + R group.
Roscovitine was dissolved in dimethyl sulfoxide following
the previously reported method [8]. 30 mg/kg roscovitine
in a volume of 8 ml was intravenously administrated
30 min before spinal ischemia started.
Examination of motor function
After 72 hours of reperfusion, twenty-eight Sprague–
Dawley rats were evaluated for the motor function of
the hind limbs using Tarlov Scoring System [12]. The
system was used to score neurological function as fol-
lows: 0, complete flexion; 1, severe incomplete flexion; 2,
could move, but could not jump; 3, jump with obvious
instability; 4, jump with slight instability; and 5, normal
motor function.
Examination of spinal ischemic infarction volume
After examination of motor function following 72 hours
of reperfusion, rats were sacrificed under deep isoflurane
anesthesia, quickly removed the spines, and measured the
infarct volume of spines. 2-mm sections were made,
stained with 2% triphenyltetra zolium chloride, and fixed
in PBS. The infarction volume was determined by using
the ImageJ software (National Institutes of Health, U.S.).
Examination of apoptosis quantity
After the evaluation of the motor function and infarction
volume, the L2-3 of lumbar spinal cord was taken. Ter-
minal deoxynucleotidyl transferase dUTP nick end label-
ing (TUNEL) technique was performed using an in situ
apoptosis detection kit (Intergen Company, USA.). The
total number of TUNEL-positive cells on each section
was counted, and expressed as the TUNEL index.
Examination of Cdk5, p35 and p25
Following 72 hours of spinal ischemia-infusion, all animals
were scarified, spinal cord was quickly removed. The
lumbar spinal cords were homogenized on ice in lysis
buffer. For analysis of p35/p25 protein expression, the
protein extracts were electrophoresed on a 12% acrylamide
SDS polyacrylamide gel electrophoresis and immunoblotted
onto polyvinylidene fluoride membranes. The membranes
were incubated with primary antibodies against p35/p25
(Cell Signaling Technology, Beverly, MA, USA), and
blocked for 1 hour at room temperature, or primary
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The bands were visualized by ECL Western blotting
analysis system (Amersham Pharmacia Biotech Europe,
Freiburg, Germany). Band intensity was quantified by
using an image analyzer (Raytest Isotopenmessgeräte,
Straubenhardt, Germany). For analysis of Cdk5 level
and activity, Western blot and immunoprecipitation
kinase activity assays were respectively performed as pre-
viously described [13,14]. Cdk5 activity was expressed as
an integrated optical density.
Statistical study
Data were expressed as mean ± SEM. Statistical analysis
of the neurologic scores was analyzed by Mann–Whitney
non-parametric test. Differences for each Cdk5 level were
analyzed by one-way ANOVA for multiple comparison
tests across time points with SPSS11.0 software. A P value
less than 0.05 were considered to be statistically significant.
Results
Before, during and after the procedure, heart rate, blood
pressure, and body temperature were kept within normal
ranges, and were similar in all groups. All animals com-
pleted the study.
Administration of BYHWD and pre-treatment of roscovitine
improved the motor function
Spinal ischemia for 60 minutes, followed by 72 hours of
reperfusion, resulted in a significant motor function
deficit, but administration of BYHWD greatly improved
the function (P < 0.05). The pre-administration of ros-
covitine significantly improved the function (P < 0.05).
There was no significant difference between BYHWDFigure 1 The motor function evaluated by Tarlov Scoring System afte
impacted the motor function, and a high score was seen in animals with
pre-treatment greatly improved the motor function. The score was higher
but there were no significant differences between the groups. **: P < 0.01 vs. C
SI + BYHWD: Spinal ischemia + BYHWD. SI + R: Spinal ischemia + Roscovitine.and roscovitine groups, even if the Scoring index was
higher in roscovitine group than that in BYHWD group
(Figure 1).Administration of BYHWD and pre-treatment of roscovitine
reduced the spinal ischemic infarction volume
Spinal ischemia for 60 minutes, followed by 72 hours of
reperfusion, resulted in an extensive spinal infarction
volume, while administration of BYHWD greatly reduced
the infarction volume (P < 0.05). The pre-administration
of roscovitine also significantly reduced the infarction
volume (P < 0.05). There was no significant difference
between BYHWD and roscovitine groups, even if the in-
farction volume was higher in roscovitine group than
that in BYHWD group (Figure 2).
No TUNEL-positive cells were seen on sham-operated
sections, but a large number of apoptotic cells was ob-
served on the ischemic tissues of the saline group. The
number of TUNEL-positive cells was significantly lower
in the BYHWD group than in the saline group (P < 0.01).
The administration of roscovitine decreased the number
of TUNEL-positive cells, but the number was higher than
that in the BYHWD group, although there was no signifi-
cant difference between the two groups (Table 1).Alteration of p35 and p25 expressions after spinal
ischemia-reperfusion
The expressions of both p35 and p25 were changed by
ischemia-reperfusion: p35 was significantly down-regulated,
while p25 was up-regulated after ischemia-reperfusion,
suggesting that p25 was up-regulated via an elevation of
cleavage of p35 (Figure 3). Alteration of p35 and p25
resulted in a hyper-activation of Cdk5.r 72-hour reperfusion. The spinal ischemia-reperfusion significantly
spinal ischemia + saline; but BYHWD administration and roscovitine
in the group with roscovitine than that in the group with BYHWD,
ontrol group. *#: P < 0.05 vs. SI + Saline. SI + Saline: Spinal ischemia + Saline.
Figure 2 The volume of spinal infarct 72 hours after reperfusion. A great infarction volume was seen in the ischemic group, but infarction
volumes were largely decreased in the animals with BYHWD administration, and roscovitine pre-treatment. The infarction volume was lower in
the group with BYHWD than that in the group with roscovitine; but there was no significant difference between the two groups. **: P < 0.01 vs.
Control group. *#: P < 0.05 vs. SI + Saline. SI + Saline: Spinal ischemia + Saline. SI + BYHWD: Spinal ischemia + BYHWD. SI + R:
Spinal ischemia + Roscovitine.
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ischemia-reperfusion
Activity and level of Cdk5 were significantly elevated after
spinal ischemia-reperfusion injury. Administration of
roscovitine greatly inhibited Cdk5. The decrease in Cdk5
activity and level was also seen by the administration of
BYHWD, indicating that BYHWD protected spine from
ischemia-reperfusion injury through inhibition of Cdk5
(Figure 4).
Discussion
In clinical practice, acute spinal ischemia may result in a
major clinical disability due to spinal infarction. For sev-
eral centuries, BYHWD has been used as a traditional
medicine for the treatment of cerobrovascular and spinalTable 1 TUNEL indices in the spinal cord after spinal
ischemia/reperfusion
Group Apoptosis Index (%)
BYHWD 7.92 ± 2.1a
Roscovitine 7.01 ± 1.2a/c
Saline 12.39 ± 2.7b
Sham 0.03 ± 0.01
a: P < 0.01, compared to the saline group.
b: P < 0.01, compared to the sham group.
c: No significant difference, compared to BYHWD group.
BYHWD group: spinal ischemia/reperfusion group with BYHWD infusion.
Roscovitine group: spinal ischemia/reperfusion group with pretreatment
of roscovitine.
Sham group: sham-operated group.
Saline group: spinal ischemia/reperfusion group with saline infusion.
BYHWD: Buyang Huanwu Decoction.diseases in eastern medicine. Some available studies on
spinal injury have been reported [15,16], but further
exploration of the exact mechanisms of BYHWD in the
neuroprotective therapy is needed. Different factors
including oxidative stress [17] and excitotoxic stimula-
tion [18], which are involved in neuronal apoptosis,
have been reported. A most recent study demonstrated
that the neuroprotective therapy of BYHWD for spinal
ischemia-reperfusion injury was through a decrease in
apoptosis [5]. The present study, using animal model, con-
firmed that BYHWD prevented the ischemia/reperfusion-
induced spinal injury, and demonstrated that the protective
function of BYHWD was, in part, through the inhibition
of Cdk5.
Apoptosis is an important mechanism in the pathogen-
esis of the secondary injury process following spinal cord
injury [19]. Apoptosis is an active gene-directed death
process mediated by activation of a number of cysteine
proteases; therefore, it may be preventable with selective
inhibitors. Cdk5 is a member of the Cdk family of serine/
threonine kinases [18], and is crucial for neuronal migra-
tion in the spinal cord [7,8]. Cdk5 activity is triggered by
its activator p35 [20]. Under pathological conditions, p35
is cleaved into a shorter form p25. The p25 fragment
triggers Cdk5 hyper-activation and translocation of the
p25/Cdk5 complex to the cytoplasm where it hyper-
phosphorylates a number of substrates, leading to neur-
onal death [21]. Roscovitine is a potent selective inhibitor
of Cdk5, and exerts protection from ischemia-reperfusion
injury in the neuronal system [9]. Many evidences have
demonstrated that administration of roscovitine inhibits
Cdk5 activity, and prevents neuronal apoptosis.
Figure 3 Expressions of p35 and p25 were alternated after spinal ischemia-reperfusion injury. p25 was up-regulated (A), p35 was
down-regulated (B), and Western blot was performed for analysis of expressions of p35 and p25 (C) after spinal ischemia-reperfusion injury.
Administration of BYHWD and roscovitine influenced the alteration of both p25 and p35 expressions. *: P < 0.05, SI + BYHWD vs. SI + Saline group.
*: P < 0.05, SI + R vs. SI + Saline group. ** P< 0.01, SI + Saline vs. Control group. SI + Saline: Spinal ischemia + saline. SI + BYHWD: Spinal ischemia + BYHWD.
SI + R: Spinal ischemia + Roscovitine.
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injury caused alterations of p25/p35, specifically in up-
regulated expression of p25 and down-regulated expression
of p35. These findings suggested that spinal ischemia-
reperfusion triggered the activation of Cdk5 through
cleavage of p35 to p25. Activation of Cdk5 results in
neuronal apoptosis, inhibition of Cdk5 protects neurons
from apoptosis [22]. Cdk5 inhibitor inhibits activity of
Cdk5 [23], and reduces neuronal apoptosis or cell death
[23,24]. In this study, the selective inhibitor of Cdk5,
roscovitine, was administrated before spinal ischemia-
reperfusion injury was made. The results from the present
study demonstrated that apoptosis was greatly prevented,
and motor function was significantly improved. Thus,these findings suggested that the neuronal apoptosis
was linked with activation of Cdk5, and that Cdk5 inhibi-
tor, roscovitine, prevented the apoptosis, and improved
the motor function. These could explain the protective
mechanisms of BYHWD therapy, because the similar
protective outcome was demonstrated in the animals
administrated with BYHWD. Therefore, the roscovitine-
like protection of BYHWD strongly suggested that the
therapeutic mechanism of BYHWD for the spinal ischemia-
reperfusion injury was linked with reduction of Cdk5.
Moreover, the neuroprotections of BYHWD against the
cellular apoptosis, motor function, and spinal infarction
caused by spinal ischemia-reperfusion injury could be due
to the fact that BYHWD not only inhibited Cdk5, but also
Figure 4 Cdk5 activity and level after spinal ischemia-reperfusion injury. Cdk5 activity was significantly elevated after spinal ischemia-
reperfusion injury. The administration of BYHWD and roscovitine greatly inhibited Cdk5 activity (A). The similar results were confirmed in Western
blot, showing that spinal ischemia-reperfusion resulted in an elevation of Cdk5 level, and that BYHWD and roscovitine inhibited Cdk5 level (B). β-
Actin was used as a loading control. *#: P < 0.05, vs. SI + Saline group. ** P < 0.01, vs. Control group SI + Saline: Spinal ischemia + saline. SI + BYHWD:
Spinal ischemia + BYHWD. SI + R: Spinal ischemia + Roscovitine.
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oxidative stress [7], glutamate [8], DNA damage and
thioredoxin system [5]. Roscovitine selectively inhibited
Cdk5 only, while BYHWD influenced multiple factors.
Therefore, findings from the present study were of import-
ance for the further exploration of multiple mechanisms
in respond to the spinal ischemia-reperfusion injury.Conclusions
Spinal ischemia-reperfusion caused a number of spinal
neuronal apoptosis and significantly damaged motor func-
tion, while administration of BYHWD greatly prevented
those injuries. Inhibition of Cdk5 activity by roscovitine
evidently protected the neuronal cells against apoptosis
or death. Our results in the present study suggested that
hyperactivity of Cdk5 was involved in the pathogenesis
of ischemia/reperfusion-induced spinal neuron apop-
tosis, and that BYHWD protected the spine against
ischemia-reperfusion injury partly through the inhib-
ition of Cdk5.Abbreviations
BYHWD: Buyang Huanwu Decoction; Cdk5: Cyclin-dependent Kinase 5;
SI: Spinal Ischemia; R: Roscovitine; TUNEL: Terminal deoxynucleotidyl
transferase dUTP nick end labeling.
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